» Articles » PMID: 25691943

Cloning and Expression of the Enzymatic Region of Streptococcal Hyaluronidase

Overview
Specialty General Medicine
Date 2015 Feb 19
PMID 25691943
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Streptococcus pyogenes produces extracellular hyaluronidase enzyme. This enzyme is directly associated with the spread of the organism during infection. The objective of the present study was to clone and express the nucleotide sequence of the enzyme which is involved in hyaluronidase enzymatic activity.

Materials And Methods: The enzymatic region of hyaluronidase gene was detected by bioinformatics method. The PCR method was used to amplify enzymatic region of hyaluronidase gene from chromosomal DNA of Streptococcus pyogenes. The eluted product was cloned into the prokaryotic expression vector pET32a which was digested by BamHI and HindIII restriction endonuclease enzymes. The target protein was expressed in the Escherichia coli. The bacteria including pET32a-hylA (hylA is abbreviation of Streptococcus pyogenes hyaluronidase gene and hylA is abbreviation of Streptococcus pyogenes hyaluronidase protein) plasmids were induced by IPTG and analyzed by SDS-PAGE. The enzymatic evaluation and antigenicity was finally studied.

Results: Enzymes digestion analysis, sequencing results showed that the target gene (1296 base pair) was inserted correctly into the recombinant vector. The expressed protein (65 KDa) was purified successfully via affinity chromatography. Data also indicated that enzymatic region of hyaluronidase protein from Streptococcus pyogenes was recognized in all 5 patient's sera.

Conclusion: In general, it is possible to produce the enzymatic regions of the Streptococcus pyogenes hyaluronidase in E. coli. The antigenic property of the produced protein is well retained. Considering the product's domestic demand and also low efficiency of production and pathogenicity of Streptococcus species, it is possible to produce it as recombinant product.

Citing Articles

HPV16 mutant E6/E7 construct is protective in mouse model.

Goodarzi M, Mosayebi G, Ganji A, Raoufi E, Sadelaji S, Babaei S BMC Biotechnol. 2024; 24(1):71.

PMID: 39350162 PMC: 11443707. DOI: 10.1186/s12896-024-00893-y.


The chimeric UreB, FliD and Omp18 proteins for a sensitive and specific diagnosis of infections.

Seyyedhamzeh H, Farajnia S, Kargar M, Baradaran B, Kafilzadeh F Iran J Microbiol. 2024; 16(3):357-365.

PMID: 39005599 PMC: 11245343. DOI: 10.18502/ijm.v16i3.15768.


Production of mutant streptavidin protein and investigation of its effect on the performance of streptavidin.

Didevara E, Sadoogh Abbasian S, Sadeghi A, Abtahi H Iran J Basic Med Sci. 2023; 26(5):572-578.

PMID: 37051096 PMC: 10083828. DOI: 10.22038/IJBMS.2023.69083.15060.


Cloning, expression and purification of antigenic fragments of the protein and its value in serology.

Darvishi F, Ganji A, Khansarinejad B, Sadoogh Abbasian S, Abtahi H Iran J Microbiol. 2023; 14(6):813-819.

PMID: 36721453 PMC: 9867610. DOI: 10.18502/ijm.v14i6.11255.


Ib-AMP4 antimicrobial peptide as a treatment for skin and systematic infection of methicillin-resistant (MRSA).

Sadelaji S, Ghaznavi-Rad E, Sadoogh Abbasian S, Fahimirad S, Abtahi H Iran J Basic Med Sci. 2022; 25(2):232-238.

PMID: 35655604 PMC: 9124539. DOI: 10.22038/IJBMS.2022.61043.13508.


References
1.
Molaee N, Abtahi H, Mosayebi G . Expression of recombinant streptokinase from streptococcus pyogenes and its reaction with infected human and murine sera. Iran J Basic Med Sci. 2013; 16(9):985-9. PMC: 3804847. View

2.
Mahmoudi S, Abtahi H, Bahador A, Mosayebi G, Salmanian A . Production of recombinant streptokinase in E. coli and reactivity with immunized mice. Pak J Biol Sci. 2010; 13(8):380-4. DOI: 10.3923/pjbs.2010.380.384. View

3.
Steer A, Vidmar S, Ritika R, Kado J, Batzloff M, Jenney A . Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not. Clin Vaccine Immunol. 2008; 16(2):172-5. PMC: 2643548. DOI: 10.1128/CVI.00291-08. View

4.
Schulze C, Bittorf T, Walzel H, Kundt G, Bader R, Mittelmeier W . Experimental evaluation of hyaluronidase activity in combination with specific drugs applied in clinical techniques of interventional pain management and local anaesthesia. Pain Physician. 2008; 11(6):877-83. View

5.
Stern R . Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol (Paris). 2005; 53(7):372-82. DOI: 10.1016/j.patbio.2004.12.021. View